Dc Investments Management, LLC Abb Vie Inc. Transaction History

Dc Investments Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $1.36 Million - $1.83 Million	-16,836 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$85.91 - $100.83 $491,233 - $576,545	5,718 Added 51.43%	16,836 $1.48 Million
Q2 2020 Aug 03, 2020	BUY	$73.37 - $98.18 $344,472 - $460,955	4,695 Added 73.1%	11,118 $1.09 Million
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $414,283 - $628,105	6,423 New	6,423 $489,000
Q4 2019 Feb 07, 2020	SELL	$72.13 - $90.25 $191,216 - $239,252	-2,651 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$62.98 - $75.72 $169,101 - $203,308	-2,685 Reduced 50.32%	2,651 $201,000
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $350,575 - $448,117	5,336 New	5,336 $388,000

3,872

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Dc Investments Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Dc Investments Management, LLC with notifications on news.